News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
226 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17922)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (356)
2 (311)
3 (275)
4 (220)
5 (5)
6 (13)
7 (269)
8 (259)
9 (234)
10 (254)
11 (151)
12 (8)
13 (5)
14 (231)
15 (262)
16 (229)
17 (233)
18 (106)
19 (13)
20 (5)
21 (200)
22 (226)
23 (228)
24 (236)
25 (117)
26 (12)
27 (4)
28 (256)
29 (245)
30 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney DiseaseFDA authorizes new IND for the study of CLBS201 in patients with reduced kidney function
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), today announced that the U.S. Food and Drug Administration (“FDA”) has authorized its investigational new drug (“IND”) application for the study of CLBS201, a CD34+ cell therapy for the treatment of diabetic kidney disease (“DKD”).
June 22, 2021
·
4 min read
Neurorehabilitation Devices Market: New Multi-electrode Stimulation Proves Efficacious in Treatment of Spinal Cord Injuries
Transparency Market Research has published a new report titled, “neurorehabilitation devices market”.
June 22, 2021
·
6 min read
Medical Cannabis Market: Increase in Use of Cannabidiol (CBD) to Drive Global Market
According to the report, the global medical cannabis market was valued at US$ 8 Bn in 2018 and is projected to grow at a rapid pace from 2019 to 2027.
June 22, 2021
·
5 min read
Rising Prevalence of Cardiovascular Diseases Propelling Acute Care Market Growth: Fact MR Study
Fact MR: The global acute care market is expected to grow at high CAGR in the assessment period, from 2021 to 2031 due to rising demand for treatment of cardio vascular diseases.
June 22, 2021
·
5 min read
Business
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
OPKO Health, Inc. announced the appointment of Katherine Stueland as President and Chief Executive Officer of GeneDx, Inc., the global genomics subsidiary of OPKO’s BioReference Laboratories.
June 22, 2021
·
4 min read
Tissue and Organ Transplantation Market Key Players Business Strategies Study Analysis Report
Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines.
June 22, 2021
·
3 min read
Previous
23 of 23